New Guidelines Aim to Reduce Long-Term Steroid Use in Severe Asthma Patients
A new protocol established by South Korean health agencies seeks to minimize the risks associated with prolonged systemic steroid treatment for severe asthma, a condition impacting a significant portion of the population.
South Korea’s National Institute of Health and the Korea Disease Control and Prevention Agency announced new standards on Thursday, July 18, designed to curtail the overuse of systemic steroids in patients battling severe asthma. The guidelines address growing concerns about the long-term side effects of these powerful medications, which are often relied upon to manage the debilitating symptoms of the disease.
Understanding the Risks of Systemic Steroids
Systemic steroids, synthetic hormones that suppress the body’s immune and inflammatory responses, are frequently prescribed for severe asthma when other treatments prove insufficient. While effective in controlling symptoms, prolonged use can lead to a cascade of adverse health consequences. Research indicates that cumulative exposure exceeding 500mg of prednisolone over a year significantly elevates the risk of developing diabetes, cardiovascular disease, and neurological disorders. A recent analysis revealed that approximately 18% of registered asthma patients in South Korea have been on systemic steroids for more than six months.
“The long-term health risks associated with repeated systemic steroid use are substantial, and proactive education is crucial,” stated a senior official from the Korea Disease Control and Prevention Agency. “Preventing side effects before they manifest is paramount.”
A Phased Approach to Steroid Reduction
The newly established standards outline a tiered approach to systemic steroid tapering, based on a patient’s daily dosage. The protocol emphasizes a gradual reduction to minimize withdrawal symptoms and maintain anti-inflammatory control.
- High Dose (Over 20mg/day): Reduce by 5mg per week.
- Medium Dose (10-20mg/day): Reduce by 2.5mg per week.
- Low Dose (Under 10mg/day): Reduce by 2.5mg every two weeks.
Crucially, the guidelines stipulate that when the dosage reaches 5mg per day, clinicians must evaluate the patient for signs of adrenal function decline and adjust the reduction rate accordingly.
Beyond Tapering: A Holistic Treatment Strategy
Recognizing the challenges of reducing steroid dependence, the research team also highlighted the importance of complementary therapies. These include:
- Increased Inhaled Steroid Dosage: Maximizing the delivery of anti-inflammatory medication directly to the lungs.
- Biological Agents: Utilizing injectable medications that target specific components of the immune system.
- Health Insurance Support: Ensuring access to these advanced treatments through adequate insurance coverage.
Impact and Future Outlook
The National Institute of Health anticipates that these new guidelines will significantly reduce both the overuse of systemic steroids and the incidence of associated side effects. “This protocol is expected to contribute to improving the quality of life for patients with severe asthma and lessening the overall social and economic burden of treatment,” explained Kim Won-ho, acting director of the National Institute for Health.
The development of these standards reflects a growing global trend toward personalized asthma management and a commitment to minimizing the long-term risks of pharmacological interventions. The study, published as an opinion paper in the Korean Journal of the Korean Society of Asthma and Allergy, underscores the importance of ongoing research and collaboration in optimizing asthma care.
